Diverse effects of G-protein-coupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells

被引:27
作者
Kita, Tsubasa [1 ]
Kadochi, Yui [1 ]
Takahashi, Kaede [1 ]
Fukushima, Kaori [1 ]
Yamasaki, Eri [1 ]
Uemoto, Taiki [1 ]
Hirane, Miku [1 ]
Fukushima, Nobuyuki [2 ]
Honoki, Kanya [3 ]
Tsujiuchi, Toshifumi [1 ]
机构
[1] Kinki Univ, Fac Sci & Engn, Dept Life Sci, Div Mol Oncol, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan
[2] Kinki Univ, Fac Sci & Engn, Dept Life Sci, Div Mol Neurobiol, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan
[3] Nara Med Univ, Dept Orthoped Surg, 840 Shijo Cho, Kashihara, Nara 6348521, Japan
关键词
GPR120; GPR40; Cell motility; Invasion; Lung cancer; PANCREATIC BETA-CELLS; INSULIN-SECRETION; GPR40; GPR120; IDENTIFICATION; EXPRESSION;
D O I
10.1016/j.yexcr.2016.03.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Free fatty acids (FFAs) are dietary nutrients which mediate a variety of biological effects through binding to G-protein-coupled FFA receptors (FFARs). G-protein-coupled receptor 120 (GPR120) and GPR40 are identified as FFARs for long- and medium-chain fatty acids. Here we investigated whether GPR120 and GPR40 are involved in the acquisition of malignant properties in lung cancer cells. Three lung cancer RLCNR, LL/2 and A549 cells used in this study expressed GPR120 and GPR40 genes. The cell motile activities of all cells were significantly suppressed by a GPR40 antagonist GW1100. In addition, GPR40 knockdown inhibited the cell motile activity of A549 cells. In gelatin zymography, matrix metalloproteinase-2 (MMP-2) activity in GPR40 knockdown was significantly lower than that in control cells. Next, to evaluate effects of GPR120 and GPR40 on cellular functions induced by anti-cancer drug, the long-term cisplatin (CDDP) treated (A549-CDDP) cells were generated. The expression levels of GPR120 and GPR40 were significantly decreased in A549-CDDP cells. While A549-CDDP cells showed the high cell motile activity, GW1100 suppressed the cell motile activity of A549-CDDP cells. These results demonstrate that GPR120 negatively and GPR40 positively regulate cellular functions during tumor progression in lung cancer cells. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 27 条
  • [1] Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes
    Bharate, Sandip B.
    Nemmani, Kumar V. S.
    Vishwakarma, Ram A.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (02) : 237 - 264
  • [2] Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules
    Briscoe, Celia P.
    Peat, Andrew J.
    McKeown, Stephen C.
    Corbett, David F.
    Goetz, Aaron S.
    Littleton, Thomas R.
    McCoy, David C.
    Kenakin, Terry P.
    Andrews, John L.
    Ammala, Carina
    Fornwald, James A.
    Ignar, Diane M.
    Jenkinson, Stephen
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) : 619 - 628
  • [3] The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
    Briscoe, CP
    Tadayyon, M
    Andrews, JL
    Benson, WG
    Chambers, JK
    Eilert, MM
    Ellis, C
    Elshourbagy, NA
    Goetz, AS
    Minnick, DT
    Murdock, PR
    Sauls, HR
    Shabon, U
    Spinage, LD
    Strum, JC
    Szekeres, PG
    Tan, KB
    Way, JM
    Ignar, DM
    Wilson, S
    Muir, AI
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) : 11303 - 11311
  • [4] A family of fatty acid binding receptors
    Brown, AJ
    Jupe, S
    Briscoe, CP
    [J]. DNA AND CELL BIOLOGY, 2005, 24 (01) : 54 - 61
  • [5] Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinorna cells reveals novel hyper- and hypomethylated targets
    Chekhun, Vasyl' F.
    Lukyanova, Nataliya Yu.
    Kovalchuk, Olga
    Tryndyak, Volodymyr P.
    Pogribny, Igor P.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (03) : 1089 - 1098
  • [6] GPR120 agonism as a countermeasure against metabolic diseases
    Cornall, Lauren M.
    Mathai, Michael L.
    Hryciw, Deanne H.
    McAinch, Andrew J.
    [J]. DRUG DISCOVERY TODAY, 2014, 19 (05) : 670 - 679
  • [7] Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion
    Edfalk, Sara
    Steneberg, Par
    Edlund, Helena
    [J]. DIABETES, 2008, 57 (09) : 2280 - 2287
  • [8] Monitoring ligand-mediated internalization of G protein-coupled receptor as a novel pharmacological approach
    Fukunaga, Shin'ichi
    Setoguchi, Shingo
    Hirasawa, Akira
    Tsujimoto, Gozoh
    [J]. LIFE SCIENCES, 2006, 80 (01) : 17 - 23
  • [9] Different roles of GPR120 and GPR40 in the acquisition of malignant properties in pancreatic cancer cells
    Fukushima, Kaori
    Yamasaki, Eri
    Ishii, Shuhei
    Tomimatsu, Ayaka
    Takahashi, Kaede
    Hirane, Miku
    Fukushima, Nobuyuki
    Honoki, Kanya
    Tsujiuchi, Toshifumi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 465 (03) : 512 - 515
  • [10] Hara T., 1841, BIOCHIM BIOPHYS ACTA, V2014, P1292